DaVita signals 2026 midpoint guidance of $2.2B adjusted operating income and $14.65 EPS while planning expanded HD rollout (NYSE:DVA)

seekingalpha.com · 2026-08-05

DaVita (DVA) Q2 2026 earnings call highlights: volume trends, EPS guidance, ESRD reimbursement risk, and expanded HD rollout—read the key takeaways now.

TickrTrends take: DaVita's 2026 guidance points to material earnings growth from its current baseline, which provides a concrete benchmark against which to assess whether the Undervalued designation can be sustained as the company executes its expanded hemodialysis rollout. The adjusted operating income and EPS targets represent specific financial milestones that valuation models typically use to project long-term cash generation in the healthcare services sector. Investors focused on valuation metrics should monitor whether the company achieves these 2026 targets, as execution risk on the HD expansion could influence whether current pricing reflects appropriate compensation for that business development.

Read the full story at seekingalpha.com →